ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm delivers IND to US FDA for Pivotal OA Program
Published: 26/03/21, 09:40am (AEST)•3 pages